These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine. Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594 [No Abstract] [Full Text] [Related]
6. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice]. Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210 [No Abstract] [Full Text] [Related]
7. Pseudomonas aeruginosa. II. Experimental acellular vaccine of an endotoxin and anatoxin type. Bĕlohlávek S; Pavlík V; Rencová J; Stránský V; Nováková L; Sourek J; Výmola F J Hyg Epidemiol Microbiol Immunol; 1987; 31(3):343-52. PubMed ID: 3119704 [TBL] [Abstract][Full Text] [Related]
8. Effects of somatic component of Pseudomonas aeruginosa on protective immunity in experimental mouse burn infection. Okada K; Kawaharajo K; Kasai T; Homma JY Jpn J Exp Med; 1980 Feb; 50(1):53-61. PubMed ID: 6770131 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model. Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930 [TBL] [Abstract][Full Text] [Related]
11. Efficiency of Pseudomonas aeruginosa vaccines in the prevention and treatment of Pseudomonas infections in burned patients. Ionescu A; Meitert E; Vasiliu S; Meitert T; Sima F; Savulian C; Milicescu S Arch Roum Pathol Exp Microbiol; 1981; 40(4):323-32. PubMed ID: 6803737 [No Abstract] [Full Text] [Related]
15. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations. Holder IA; Naglich JG J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208 [TBL] [Abstract][Full Text] [Related]
16. Bacteriological and histopathological estimation of Aerodin efficacy administered by respiratory way to mice and guinea pigs experimentally infected. Popescu C; Pencea I; Anton D; Hoisie S; Leibovici AD; Leibovici M; Grigoras E; Thirer O Arch Roum Pathol Exp Microbiol; 1979; 38(2):155-66. PubMed ID: 122262 [No Abstract] [Full Text] [Related]
17. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections. Pier G Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066 [TBL] [Abstract][Full Text] [Related]
18. [Donor plasma with anti-Pseudomonas aeruginosa activity as a directed-action preparation]. Nazarchuk LV Vrach Delo; 1987 Jul; (7):96-8. PubMed ID: 3114958 [No Abstract] [Full Text] [Related]
19. [Pyocyanic infection in burned patients. Immunitary protection]. Moyen EN; Lesage D; Romano P Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061 [No Abstract] [Full Text] [Related]
20. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns. Neely AN; Holder IA Antibiot Chemother (1971); 1987; 39():26-40. PubMed ID: 3118788 [No Abstract] [Full Text] [Related] [Next] [New Search]